SPOTLIGHT -
Slideshow
Author(s):
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Psychiatric Times Through the Years: The Last 5 Years in February Covers
Blue Light Blockers: A Behavior Therapy for Mania
What Went Wrong? Top 6 Clinical Disappointments
Blue Light, Depression, and Bipolar Disorder
AXS-05 Demonstrates Efficacy and Manageable Adverse Effects in Major Depressive Disorder Treatment
SPN-820 Shows Rapid and Significant Improvement in Major Depressive Disorder Symptoms